Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Key-properties outlook of novel microparticulate platforms for bone therapeutic targeting

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: BETTENCOURT, Ana (Faculty of Pharmacy, Universidade de Lisboa, Ciencias Toxicologicas e Bromatologicas, Lisboa, Portugal)
  • Co-author(s): Ana Bettencourt: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
    Ines Santos-Ferreira: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
    Judith Kikhney: Biofilmcenter, Deutsches Herzzentrum Berlin, Charité – Universitätsmedizin Berlin, Germany, Germany
    Isabel Ribeiro: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
    Lidia Gonçalves: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
    Andrej Trampuz: Center for Musculoskeletal Surgery, Charité – Universitätsmedizin Berlin, Germany
    Annette Moter: Biofilmcenter, Deutsches Herzzentrum Berlin, Charité – Universitätsmedizin Berlin, Germany, Germany
    António Almeida: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
  • Abstract:

    Backgrounds

    Conventionally, complicated bone infections caused by Gram-positive bacteria are treated with vancomycin. However, emergence of resistant Staphylococci to vancomycin led to the increased use of daptomycin. Nevertheless, in severe bone infections, daptomycin efficacy is often limited, due to insufficient drug bioavailability at the

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses